Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COALA: Choline Alfoscerate in Alzheimer's Disease
NCT05383183Phase 4Recruiting
- Sponsor
- Daewoong Bio
- Start
- Jan 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of choline alfoscerate in Alzheimer's disease (AD), sponsored by Daewoong Bio. Started Jan 2022; status: recruiting.
02
Drugs
choline alfoscerate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05383183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05383183.